accountDrugmakers Eli Lilly and Bristol-Myers Squibb both reported better-than-expected second quarter earnings, helped by cost controls, sending shares higher in pre-market trading Thursday...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Eli Lilly and Bristol Beat Forecasts on Cost Controls
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account